1. Home
  2. WAL vs SYRE Comparison

WAL vs SYRE Comparison

Compare WAL & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WAL

Western Alliance Bancorporation (DE)

N/A

Current Price

$77.56

Market Cap

8.8B

Sector

Finance

ML Signal

N/A

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

N/A

Current Price

$87.73

Market Cap

8.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WAL
SYRE
Founded
1994
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.5B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
WAL
SYRE
Price
$77.56
$87.73
Analyst Decision
Buy
Strong Buy
Analyst Count
14
12
Target Price
$91.69
$85.08
AVG Volume (30 Days)
810.7K
945.1K
Earning Date
04-21-2026
05-08-2026
Dividend Yield
2.11%
N/A
EPS Growth
23.13
N/A
EPS
3.99
N/A
Revenue
$135,800,000.00
N/A
Revenue This Year
$20.49
N/A
Revenue Next Year
$8.08
N/A
P/E Ratio
$19.58
N/A
Revenue Growth
99.71
N/A
52 Week Low
$65.82
$14.51
52 Week High
$97.23
$110.18

Technical Indicators

Market Signals
Indicator
WAL
SYRE
Relative Strength Index (RSI) 37.10 32.38
Support Level $73.93 $81.65
Resistance Level $84.75 $106.10
Average True Range (ATR) 1.61 4.60
MACD -0.33 -2.56
Stochastic Oscillator 3.94 9.59

Price Performance

Historical Comparison
WAL
SYRE

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: